Poniard Pharmaceuticals, Inc.
PARD
$0.0001
$0.000.00%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Net Income | -16.04M | -18.72M | -21.41M | -30.05M | -38.05M |
| Total Depreciation and Amortization | 1.28M | 1.29M | 1.30M | 1.31M | 1.33M |
| Total Amortization of Deferred Charges | 256.00K | 499.00K | 764.00K | 1.08M | 1.15M |
| Total Other Non-Cash Items | 4.84M | 5.36M | 6.31M | 10.32M | 12.44M |
| Change in Net Operating Assets | -782.00K | -1.05M | -4.92M | -6.94M | -4.58M |
| Cash from Operations | -10.46M | -12.62M | -17.95M | -24.28M | -27.71M |
| Capital Expenditure | -9.00K | -16.00K | -14.00K | -7.00K | -10.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 16.00K | 17.00K | 58.00K | 73.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.24M | 18.89M | 25.48M | 23.97M | 8.25M |
| Cash from Investing | 12.23M | 18.89M | 25.48M | 24.03M | 8.31M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.80M | -15.77M | -17.74M | -20.43M | -8.63M |
| Issuance of Common Stock | 3.18M | 3.18M | 3.18M | 6.09M | 20.23M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -192.00K | -192.00K | -192.00K | -192.00K | -346.00K |
| Other Financing Activities | 0.00 | 0.00 | 123.00K | 123.00K | 123.00K |
| Cash from Financing | -10.81M | -12.78M | -14.63M | -14.40M | 11.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.03M | -6.51M | -7.10M | -14.65M | -8.02M |